LRP5 Antibodies

Santa Cruz Biotechnology features a diverse variety of LRP5 monoclonal antibodies for research focused on understanding LRP5 protein function. LRP5 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRP5, or Low-Density Lipoprotein Receptor-Related Protein 5, plays a central role in the Wnt signaling pathway, which regulates cell proliferation, differentiation, and tissue homeostasis. Abnormal LRP5 function has been linked to several conditions, including osteoporosis and various types of cancer, highlighting its importance as a therapeutic target. Research utilizing LRP5 monoclonal antibodies enables deeper understanding of cellular mechanisms and disease processes. Investigating LRP5 can reveal new insights into bone development, metabolism, and cancer progression. Scientists worldwide rely on LRP5 monoclonal antibodies to explore novel therapeutic strategies and advance medical research. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to scientific discovery and therapeutic development.